Exploration biologique fonctionnelle thyroïdienne : Les pièges à éviter

Revue de Medecine Interne

Volumn 20, Issue SUPPL. 1, 1999, Pages 9-11

  Sapin, R ^a   Schlienger, J L ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROTROPIN; THYROXINE;

AGE; AGED; BLOOD; CHILD; DRUG THERAPY; HUMAN; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; THYROID DISEASE; THYROID FUNCTION TEST; THYROID GLAND;

AGE FACTORS; AGED; CHILD; DRUG THERAPY; HUMANS; THYROID DISEASES; THYROID FUNCTION TESTS; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

EID: 2042533957     PISSN: 02488663     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0248-8663(99)80124-6     Document Type: Article

References (24)

1. Spencer CA, Takeuchi M, Kazarosyan M. Current status and performance goals of thyrotropin (TSH) assays. Clin Chem 1996; 42: 140-5.
2. Sheehan CP, Christofides NC. One-step labeled-antibody assay for measuring free thyroxin. II. Performance in a multicenter trial. Clin Chem 1992; 38: 19-25.
3. Sapin R, Schlienger JL, Goichot B, Gasser F, Grucker D. Evaluation of Elecsys free-triiodothyronine assay: relevance of age-related reference ranges. Clin Biochem 1998; 31: 399-404.
4. Glinoer D, De Nayer P, Robyn C, Lejeune B, Klinthaert J, Meuri S. Serum levels of intact chorionic gonadotrophin (HCG) and its free alpha and beta subunits in relation to maternal thyroid stimulation during pregnancy. J Endocrinol Invest 1993; 16: 881-8.
5. Ball R, Freedman DB, Holmes JC, Midgley JE, Sheehan CP. Low-normal concentrations of free thyroxin in serum in late pregnancy: physiological fact not technical artefact. Clin Chem 1989; 35: 1891-6.
6. Surks MI, Sievert R. Drugs and thyroid function. N Engl J Med 1995; 333: 1688-94.
7. Davies PH, Franklyn JA. The effects of drugs on tests of thyroid function. Eur J Clin Pharmacol 1991; 40: 439-51.
8. Wemeau JL. Modifications de la fonction thyroïdienne induite par les médicaments. In : Leclère J, Orgiazzi J, Rousset B, Schlienger JL, Wemeau JL, éd. La thyroïde. Paris : Expansion Scientifique; 1992. p. 527-41.
9. Stockigt JR, Lim CF, Barlow JW, et al. Interaction of furosemide with serum thyroxin-binding sites: in vivo and in vitro studies and comparison with other inhibitors. J Clin Endocrinol Metab 1985; 60: 1025-31.
10. Suzuki Y, Nanno M, Gemma R, Yoshimi T. Plasma free fatty acids, inhibitor of extrathyroidal conversion of T4 to T3 and thyroid hormone binding inhibitor in patients with various nonthyroidal illnesses. Endocrinol Jpn 1992; 39: 445-53.
11. Lim CF, Stockigt JR. Influence of uremic toxins and nonesterified fatty acids on drug and thyroid hormone binding in serum. Clin Chem 1998; 44: 2380-1.
12. Jaume JC, Mendel CM, Frost PH, Greenspan FS, Laughton CW. Extremely low doses of heparin release lipase activity into the plasma and can thereby cause artifactual elevation in the serum-free thyroxine concentration as measured by equilibrium dialysis. Thyroid 1996; 6: 79-83.
13. Stevenson HP, Archbold GP, Johnston P, Young IS, Sheridan B. Misleading serum free thyroxine results during low molecular weight heparin treatment. Clin Chem 1998; 44: 1002-7.
14. Sapin R, D'Herbomez M, Gasser F, Wemeau JL, Schlienger JL. Analytical limitations of thyrotropin assays. J Clin Ligand Assay 1996; 19: 198-202.
15. Depres N, Grant A. Antibody interference in thyroid assays: a potential for clinical misinformation. Clin Chem 1998; 44: 440-54.
16. Sapin R, Schlienger JL, Gasser F, Chambron J. Anti-triiodothyronine auto-antibody interference in recent free thyroid hormone assays. Clin Biochem 1996; 29: 89-92.
17. Norden AG, Jackson RA, Norden LE, Griffin AJ, Barnes MA, Little JA. Misleading results from immunoassays of serum free thyroxine in presence of rheumatoid factor. Clin Chem 1997; 43: 957-62.
18. Sapin R, Schlienger JL, Grunenberger F, Gasser F, Chambron J. Fausses élévations de la fraction libre des hormones thyroïdiennes : importance de la méthode de dosage. Rev Fr Endocrinol Clin 1996; 37: 5-16.
19. Hawkins RC. Furosemide interference in newer free thyroxine assays. Clin Chem 1998; 44: 2550-1.
20. Surks MI, DeFesi CR. Normal serum free thyroid hormone concentrations in patients treated with phenytoin or carmabazepine. A paradox resolved. JAMA 1996; 275: 1495-8.
21. Okabayashi T, Takeda K, Kawada M, et al. Free thyroxine concentrations in serum measured by equilibrium dialysis in chronic renal failure. Clin Chem 1996; 42: 1616-20.
22. Sapin R, Schlienger JL, Kaltenbach G, et al. Determination of free triiodotnyronine by six different methods in patients with non-thyroidal illness and in patients treated with amiodarone. Ann Clin Biochem 1995; 32: 314-24.
23. Nelson JC, Weiss RM, Wilcox RB. Underestimates of serum free thyroxine (T4) concentrations by free T4 immunoassays. J Clin Endocrinol Metab 1994; 79: 76-9.
24. Ekins R. One step labeled-antibody assay for measuring free thyroxine. I. Assay development and validation. Clin Chem 1992: 38: 2355-8.